For guest writer Aranzazu Calzado, there's nothing like a wall to remind her that having something to lean on is not about ...

The company recently hit significant roadblocks with its BTK inhibitor, but there are plenty of fish in the sea for the drug ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...

Other prenatal exposures -- preterm birth (before 37 weeks gestation), placental abruption, and maternal hypertensive ...

Recent findings suggest that the Epstein-Barr virus (EBV) is involved in both causing multiple sclerosis (MS) and shaping its ...

Machine learning can help predict whether people newly diagnosed with MS will experience disability worsening that occurs ...

Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.

A long-term study has identified a potential biomarker that could help detect which patients are progressing toward more severe forms of multiple sclerosis.

One of the leading triggers for multiple sclerosis (MS) is an infection with the Epstein-Barr virus. However, certain gene variants also play an important role.

Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself. Yet for most of ...

NICE recommends natalizumab as a new treatment for adults with highly active relapsing-remitting multiple sclerosis ...

In May 2022, The US FDA authorized the use of RADICAVA ORS (edaravone) in an oral formulation for the treatment of ALS.